<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article">
 <front>
  <journal-meta>
   <journal-id journal-id-type="publisher-id">
    ojsst
   </journal-id>
   <journal-title-group>
    <journal-title>
     Open Journal of Safety Science and Technology
    </journal-title>
   </journal-title-group>
   <issn pub-type="epub">
    2162-5999
   </issn>
   <issn publication-format="print">
    2162-6006
   </issn>
   <publisher>
    <publisher-name>
     Scientific Research Publishing
    </publisher-name>
   </publisher>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="doi">
    10.4236/ojsst.2025.154016
   </article-id>
   <article-id pub-id-type="publisher-id">
    ojsst-146520
   </article-id>
   <article-categories>
    <subj-group subj-group-type="heading">
     <subject>
      Articles
     </subject>
    </subj-group>
    <subj-group subj-group-type="Discipline-v2">
     <subject>
      Chemistry 
     </subject>
     <subject>
       Materials Science, Earth 
     </subject>
     <subject>
       Environmental Sciences, Engineering, Physics 
     </subject>
     <subject>
       Mathematics, Social Sciences 
     </subject>
     <subject>
       Humanities
     </subject>
    </subj-group>
   </article-categories>
   <title-group>
    Asbestos Exposure and Mesothelioma: Historical Insights and Modern Technological Impacts in the USA
   </title-group>
   <contrib-group>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Robb
      </surname>
      <given-names>
       Shawe
      </given-names>
     </name>
    </contrib>
   </contrib-group> 
   <aff id="affnull">
    <addr-line>
     aDepartment of Occupational Health and Safety, Capitol Technology University, Laurel, MD, USA
    </addr-line> 
   </aff> 
   <pub-date pub-type="epub">
    <day>
     22
    </day> 
    <month>
     10
    </month>
    <year>
     2025
    </year>
   </pub-date> 
   <volume>
    15
   </volume> 
   <issue>
    04
   </issue>
   <fpage>
    301
   </fpage>
   <lpage>
    310
   </lpage>
   <history>
    <date date-type="received">
     <day>
      11,
     </day>
     <month>
      August
     </month>
     <year>
      2025
     </year>
    </date>
    <date date-type="published">
     <day>
      19,
     </day>
     <month>
      August
     </month>
     <year>
      2025
     </year> 
    </date> 
    <date date-type="accepted">
     <day>
      19,
     </day>
     <month>
      October
     </month>
     <year>
      2025
     </year> 
    </date>
   </history>
   <permissions>
    <copyright-statement>
     © Copyright 2014 by authors and Scientific Research Publishing Inc. 
    </copyright-statement>
    <copyright-year>
     2014
    </copyright-year>
    <license>
     <license-p>
      This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/
     </license-p>
    </license>
   </permissions>
   <abstract>
    Asbestos exposure remains a critical public health concern in the United States due to its well-established link with mesothelioma. Understanding how risk is estimated and how modern advancements are improving exposure assessment is essential for prevention and policy. Researchers rely on retrospective cohort and case-control study designs to reconstruct past exposures and analyze the dose-response relationship between asbestos and mesothelioma. Significant challenges include missing records, the long latency period of asbestos-related diseases, and the complexity of reconstructing both occupational and non-occupational exposures. Modern tools such as electronic archives and artificial intelligence now help fill data gaps and make exposure assessments more reliable. By combining expertise from medicine, data science, and policy, collaborative approaches are shaping exposure limits and regulations. Studying the past with new technologies is guiding future prevention of mesothelioma and enhancing public health protection.
   </abstract>
   <kwd-group> 
    <kwd>
     Asbestos Exposure
    </kwd> 
    <kwd>
      Mesothelioma
    </kwd> 
    <kwd>
      Retrospective Cohort
    </kwd> 
    <kwd>
      Case-Control Studies
    </kwd> 
    <kwd>
      Dose-Response
    </kwd> 
    <kwd>
      AI
    </kwd> 
    <kwd>
      Regulatory Frameworks
    </kwd> 
    <kwd>
      Occupational Health
    </kwd> 
    <kwd>
      Epidemiology
    </kwd> 
    <kwd>
      Digital Archives
    </kwd> 
    <kwd>
      Biomarker Discovery
    </kwd> 
    <kwd>
      Industrial Hygiene
    </kwd> 
    <kwd>
      Risk Assessment
    </kwd> 
    <kwd>
      Exposure Reconstruction
    </kwd> 
    <kwd>
      Latency Period
    </kwd> 
    <kwd>
      Public Health Policy
    </kwd>
   </kwd-group>
  </article-meta>
 </front>
 <body>
  <sec id="s1">
   <title>1. Introduction</title>
   <p>It is important to analyze asbestos exposure from all possible perspectives, as this mineral is a well-established cause of a rare and highly fatal disease—mesothelioma, which continues to be a significant public health issue in the US. Numerous industries have utilized it, and due to the long latency of asbestos-related diseases, today’s asbestos exposure levels and future implications must be considered, in addition to the historical use of asbestos. Growth in mesothelioma incidence highlights the need for robust methodologies that would allow more accurate assessments of mesothelioma and asbestos exposure risks. Regulatory measures, such as those introduced by OSHA, and public awareness campaigns have played a crucial role in reducing exposure and changing public perception. Successful implementation of safety practices, both in the US and in comparable countries like Australia and New Zealand, demonstrates the importance of strong regulations and public education in minimizing future asbestos-related health risks.</p>
  </sec><sec id="s2">
   <title>
    <xref ref-type="bibr" rid="scirp.146520-"></xref>2. Historical Overview of Asbestos Use and Exposure</title>
   <p>Asbestos use in the United States represents how prevalent its usage was in different industries, particularly construction, shipyard, automotive, and other manufacturing sectors. Asbestos was prized and used for its thermal resistance and strength starting in the early twentieth century, when most workers were exposed at the job sites <xref ref-type="bibr" rid="scirp.146520-1">
     [1]
    </xref>. Given its renown, worker exposure was particularly high, especially prior to regulations and the prohibition on its use. Over the decades, methods of measurement and approaches to exposure have improved, from simple sampling methods to sophisticated techniques like electron microscopy, which demonstrated exposure <xref ref-type="bibr" rid="scirp.146520-2">
     [2]
    </xref>. These lessons on exposures are key in risk assessment and management for understanding the relevance of exposures for current impacts and future initiatives for workers who are still affected (see <xref ref-type="fig" rid="fig1">
     Figure 1
    </xref>).</p>
   <fig id="fig1" position="float">
    <label>Figure 1</label>
    <caption>
     <title>
      <xref ref-type="bibr" rid="scirp.146520-"></xref>Figure 1. Schematic diagram: Quantification of historical U.S. asbestos use.</title>
    </caption>
    <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/1480464-rId13.jpeg?20251022111432" />
   </fig>
  </sec><sec id="s3">
   <title>
    <xref ref-type="bibr" rid="scirp.146520-"></xref>3. Epidemiological Approaches to Risk Analysis</title>
   <p>The key to establishing the association between asbestos exposure and the development of mesothelioma is through well-conducted epidemiological studies. The most commonly utilized designs for asbestos MESO studies are retrospective cohort studies and case-control studies. Epidemiological studies provide key statistical evidence that highlights the correlation between asbestos exposure and mesothelioma <xref ref-type="bibr" rid="scirp.146520-3">
     [3]
    </xref>. By utilizing databases such as the Global Cancer Observatory, researchers can analyze the trends of incidence, demographics, geography, and rationale of diseases <xref ref-type="bibr" rid="scirp.146520-2">
     [2]
    </xref>. Therefore, these epidemiological studies are crucial in understanding the impact of asbestos exposure and improving policy, enhancing health and safety governance to minimize future exposure attributable to mesothelioma.</p>
   <sec id="s3_1">
    <title>
     <xref ref-type="bibr" rid="scirp.146520-"></xref>3.1. Retrospective Cohort Study Design</title>
    <p>Retrospective cohort studies are also paramount in establishing the link between asbestos exposure and mesothelioma, as they follow an asbestos-exposed population for years and study the effects of this exposure on their health. Retrospective cohort studies utilize the historical records of many industries and employ them along with medical history to identify the asbestos exposure dosage and quantity in patients, helping researchers understand the level of occupational asbestos exposure <xref ref-type="bibr" rid="scirp.146520-2">
      [2]
     </xref>. As this method tracks a specific exposed population with diagnosed mesothelioma and compares it to a non-exposed population with one or many similar traits, researchers can find a positive correlation between the asbestos exposure dosage and the incidence of contracting mesothelioma, placing them at high risk of developing the disease <xref ref-type="bibr" rid="scirp.146520-3">
      [3]
     </xref>. In this way, it also helps to elucidate the latency period between the time of exposure and the development of symptoms related to mesothelioma, as patients exposed to asbestos show symptoms after several years, and sometimes decades, of exposure. Hence, a targeted public health intervention can be established for individuals at high risk based on the identified history of asbestos exposure prevalent in this cohort.</p>
   </sec>
   <sec id="s3_2">
    <title>
     <xref ref-type="bibr" rid="scirp.146520-"></xref>3.2. Utilizing Case-Control Studies</title>
    <p>The availability of case-control studies showing an association between exposure to asbestos and mesothelioma is a major advantage of the case-control design. Case-control studies are well-suited to the investigation of this association because mesothelioma is rare, and the case-control design facilitates the investigation of potential etiological factors without the need to wait for new cases to accumulate over time. An example is the study conducted in Lombardy, Italy, using data from regional cancer registries to describe an association between asbestos exposure and peritoneal mesothelioma <xref ref-type="bibr" rid="scirp.146520-4">
      [4]
     </xref>. By selecting an appropriate control group that is comparable to the case group in every respect except for the disease of interest, researchers can often discern differences in terms of exposure that might account for the findings. The outcomes of such studies can provide valuable information that aids in understanding risk factors and in the development of improved protective measures against asbestos-related disease.</p>
   </sec>
  </sec><sec id="s4">
   <title>
    <xref ref-type="bibr" rid="scirp.146520-"></xref>4. Reconstructing Historical Exposure Levels</title>
   <p>Most importantly, reconstructing past exposure scenarios is vital for restoring the historical implications of asbestos exposure on workers’ health. This requires in-depth research through archives to reconstruct asbestos exposure scenarios based on previously assembled epidemiological data. By applying historical reconstructive analysis of industrial exposure, it is possible to recreate the workplace environment associated with sectors like milling, mining, manufacturing, or maritime <xref ref-type="bibr" rid="scirp.146520-1">
     [1]
    </xref>. The role of microscopic examination, whereas lower transmission electron microscopy and personal exposure sampling were utilized for estimating airborne asbestos concentration (AAC), is significant in determining the implications of workplace asbestos exposure on the health of individuals. Today, with the help of digital advancements, scientists can interpret data exposure even from long-past decades and replicate past exposure scenarios to create a more generalized reflection of workplaces <xref ref-type="bibr" rid="scirp.146520-2">
     [2]
    </xref>. Such approaches not only help in understanding and investigating the historical exposure rates and the long latencies of diseases (e.g., mesothelioma), but also assist in drawing parallels in exposure conditions and current standards to better understand and define the correct levels of exposure limits.</p>
   <sec id="s4_1">
    <title>
     <xref ref-type="bibr" rid="scirp.146520-"></xref>4.1. Sources of Exposure Data</title>
    <p>Finding good sources of exposure data is crucial for piecing together how asbestos affected people in the past. Some of the best sources are industrial measurements and job records, which can show exactly how and where people were exposed. Early on, exposure was measured with basic sampling. However, over time, new techniques like analytical electron microscopy made it possible to obtain much more detailed information about the types and sizes of asbestos fibers <xref ref-type="bibr" rid="scirp.146520-1">
      [1]
     </xref>. Job records help fill in the gaps by showing what roles people had and how long they worked in certain places. By putting all this information together, researchers can better identify who was at risk and help set better rules to keep workers safe today.</p>
   </sec>
   <sec id="s4_2">
    <title>
     <xref ref-type="bibr" rid="scirp.146520-"></xref>4.2. Challenges in Data Accuracy and Completeness</title>
    <p>Reconstruction of past asbestos exposure levels faces difficulties mainly due to the complexity and incompleteness of historical data. One of the main difficulties is the lack of early and accurate record-keeping systems to report precise levels and conditions of exposure to asbestos in different workplaces <xref ref-type="bibr" rid="scirp.146520-3">
      [3]
     </xref>. Alongside gradual record loss, many companies failed to maintain detailed records during the later stages of workplace exposure. When attention to record-keeping and other developments also included the destruction of records due to the closure of operations, mergers, and other developments, this contributed to the lack of historical data. These challenges result in incomplete assessments of historical exposure dates, leading to inaccurate assessments of past asbestos exposure situations. While the effect of technological advancements such as digital archiving and data recovery processes has somewhat provided relief for most of these difficulties, the long-lasting latency effect of asbestos diseases still underlines the need for careful reconstruction of past exposures from incomplete historical data <xref ref-type="bibr" rid="scirp.146520-3">
      [3]
     </xref>.</p>
    <p>In addition, the time lag characteristics of diseases caused by asbestos present a unique hazard for the precision principle and the reconstruction of exposures. Diseases with a long time lag (often decades) hinder the identification of a causal relationship between exposure and the onset of the disease. Non-linear cancer dose-response models suggest that lengthy exposure times may increase the complexity of dose-response associations with epidemiological data <xref ref-type="bibr" rid="scirp.146520-5">
      [5]
     </xref>. Long exposure times considerably complicate the need for precision to reconstruct the exposure years with abuses; complex dose-response transformations necessitate data analysis techniques that can compensate for the prolonged time to the disease and the absence of historical data. As such, the time lag has created a greater need for protection against mesothelioma exposure based on mathematical modeling and sophisticated data analysis techniques.</p>
   </sec>
  </sec><sec id="s5">
   <title>
    <xref ref-type="bibr" rid="scirp.146520-"></xref>5. Dose-Response Analysis and Medical Record Utilization</title>
   <p>Exposure-response assessment of asbestos-related diseases is a statistical technique involving the risk assessment of the relationship between asbestos exposure and health outcomes. Through the analysis of exposure-response assessment, a dose-response model is developed. Statistical projection is based on existing data related to asbestos exposure and evaluates different factors to finalize expected health outcome projections affected by asbestos exposure <xref ref-type="bibr" rid="scirp.146520-6">
     [6]
    </xref>. Before finalizing any decision, expert modelers review the disease mechanisms and then use statistically significant medical literature to frame accurate projections. Through continuous medical data analysis, sensitive populations and vulnerable occupations are identified. This identification helps in developing protective standards that not only estimate the probability of exposure-response but also evaluate protective levels.</p>
   <p>Additionally, statistical models aid in the interpretation of dose-response data, which is the relationship between the exposure level and the health risks. The models are used to estimate the effect of asbestos safe thresholds and the importance of the age at first exposure rather than the duration of exposure <xref ref-type="bibr" rid="scirp.146520-7">
     [7]
    </xref>. Using these methods, the researchers can provide a more scientifically grounded recommendation for the policy implications, ensuring that legislation safeguards public health.</p>
  </sec><sec id="s6">
   <title>
    <xref ref-type="bibr" rid="scirp.146520-"></xref>6. Technological Advancements in Exposure Assessment</title>
   <p>New technological advances have improved pleural plaque assessment and, consequently, their tracing over time and estimation of risks related to asbestos exposure. AI technologies permit the development of automated methods for quantifying pleural plaques, and AI analysis can accurately evaluate pleural plaques in CT scans <xref ref-type="bibr" rid="scirp.146520-8">
     [8]
    </xref>. New digital assessment methods and tools have been incorporated into different analytical techniques (such as phase contrast microscopy, analytical electron microscopy, among others) to determine airborne concentrations, fiber, and particle characteristics <xref ref-type="bibr" rid="scirp.146520-1">
     [1]
    </xref>. Assessment methodologies that integrate these tools provide a deeper understanding of asbestos exposure and its health effects, thereby supplying impactful information about asbestos exposure during occupational health practices and legislative measures to reduce asbestos exposure.</p>
   <sec id="s6_1">
    <title>6.1. Case Study: AI-Based Pleural Plaque Detection in the United States</title>
    <p>A 2022 study conducted at a major U.S. academic medical center applied artificial intelligence algorithms to chest CT scans of retired shipyard and construction workers with known asbestos exposure. The AI system automatically quantified pleural plaques, achieving near-expert accuracy and substantially reducing the time required for analysis compared to manual methods. The results enabled longitudinal tracking of plaque progression and improved risk stratification for mesothelioma surveillance. This case demonstrates how AI-based detection is transforming exposure assessment and disease monitoring in real-world U.S. settings <xref ref-type="bibr" rid="scirp.146520-8">
      [8]
     </xref>.</p>
   </sec>
   <sec id="s6_2">
    <title>
     <xref ref-type="bibr" rid="scirp.146520-"></xref>6.2. Role of AI and Digital Archives</title>
    <p>Advancements in the field of AI and digital archives have drastically improved the efficiency and accuracy of exposure assessments related to asbestos. Automated exposure assessment can be exemplified through the use of AI technologies like deep learning algorithms that have shown promising application in quantifying pleural plaques (which are used to determine asbestos exposure). One study showed that AI quantification was precise in determining pleural plaques from CT scans, with an agreement close to that of experts and less time taken in analyzing CT scans <xref ref-type="bibr" rid="scirp.146520-8">
      [8]
     </xref>. Another use of digitized archives is that they can provide historians and epidemiologists with easy access to records related to historical data of exposure timeliness, which assists in further analysis and expansion on initial findings concerning timing and health impacts. Overall, these technologies contribute to obtaining better quality data about disease monitoring and exposure assessments for diseases related to asbestos, making them more streamlined in defining exposure-related assessments and implications for health policies.</p>
   </sec>
   <sec id="s6_3">
    <title>
     <xref ref-type="bibr" rid="scirp.146520-"></xref>6.3. Advances in Imaging and Biomarker Technologies</title>
    <p>Imaging tools and biomarker technology have advanced significantly, increasing the accuracy of method development for diagnosing mesothelioma. Imaging tools, including CT scans, enable high-resolution methods to identify asbestos-induced lung changes, including pleural plaques that serve as markers of exposure <xref ref-type="bibr" rid="scirp.146520-8">
      [8]
     </xref>. Deep learning algorithms also improve methods to identify and quantify pleural plaques, increasing accuracy and reducing the time needed for manual analysis. Furthermore, research into biomarker technology provides a platform to identify biological markers that indicate mesothelioma-related molecular changes in patients before the advent of clinical signs <xref ref-type="bibr" rid="scirp.146520-6">
      [6]
     </xref>. Therefore, these advancing technologies provide a valuable platform for clinicians to develop accurate early diagnostic methods for asbestos-associated conditions, improving the overall prognosis.</p>
   </sec>
  </sec><sec id="s7">
   <title>
    <xref ref-type="bibr" rid="scirp.146520-"></xref>7. Policy Impacts and Regulatory Frameworks</title>
   <p>The impact of scientific evidence about asbestos exposure on the formulation of policies and standards is of great importance. Scientific risk assessment and regulation are essential for controlling and assessing health risks posed by asbestos. Regulations use epidemiological evidence to determine acceptable exposure limits for workers and the public, reflecting asbestos’s carcinogenic potential. Legal frameworks include standards and oversight programs to control asbestos use and ensure safe demolition and disposal. While contemporary OSHA-level regulations provide considerable workplace protection, enforcement and monitoring gaps persist, especially in the US. Emerging technologies, such as AI-based diagnostics and improved disposal techniques, offer opportunities to enhance regulatory compliance and health protection. Lessons from Australia and New Zealand suggest that robust monitoring, disposal technologies, and public awareness campaigns can further strengthen regulatory frameworks and promote occupational health.</p>
   <sec id="s7_1">
    <title>
     <xref ref-type="bibr" rid="scirp.146520-"></xref>7.1. Interdisciplinary Collaborations</title>
    <p>Epidemiologists, toxicologists, and data scientists need to work together in developing asbestos policy. The knowledge and expertise of epidemiologists, who provide evidence on disease patterns, causes, and effects due to asbestos exposure, will play a significant role in creating policies related to asbestos exposure limits and prevention <xref ref-type="bibr" rid="scirp.146520-9">
      [9]
     </xref>. Toxicologists will also help policymakers understand the effects of asbestos exposure on human biology, and have a precise knowledge of the dose-response relationship and its associated risk. Data scientists can further assist through the use of data modeling tools and computational technologies. Together, this team can analyze and interpret a significant dataset that reveals exposure patterns and can possibly predict models. This collaboration can help policymakers develop a more accurate, comprehensive risk assessment of asbestos and its impact on health, informed by scientific evidence and evidence-based approaches.</p>
   </sec>
   <sec id="s7_2">
    <title>
     <xref ref-type="bibr" rid="scirp.146520-"></xref>7.2. Influences on Risk Assessment and Standards</title>
    <p>The use of dose-response models and biomarker validation is significant in developing risk assessment and regulation of allowable exposure limits on asbestos-related public health. Under this method, a physiologically based pharmacokinetic model is used in dose-response analysis for quantifying asbestos exposures, which can estimate exposures that are unlikely to increase the cancer risk over a “normal human lifespan” <xref ref-type="bibr" rid="scirp.146520-7">
      [7]
     </xref>. In establishing regulatory exposure limits, assessing the exposures that can or cannot increase asbestos-related risk to humans allows regulators to determine an allowable exposure limit with an adequate “safety margin” for workers exposed to asbestos to help mitigate the added public health impact of mesothelioma. Additionally, biomarker validation enables the identification of biological effects of asbestos exposure, allowing improved detection, diagnosis, and monitoring of asbestos-related diseases <xref ref-type="bibr" rid="scirp.146520-3">
      [3]
     </xref>. The use of these scientific methods and tools ensures that risk assessments are not just aligned with applicable regulatory policies but are also based on scientific and empirical evidence.</p>
    <p>Additionally, future research on asbestos should focus on integrating emerging technologies and policy research to address the changing trends that will impact how exposure is assessed and managed to prevent mesothelioma from asbestos exposure. The advancements being made in AI on exposure assessment studies should be adapted into future research efforts to improve current standards and make future research findings more progressive, thereby making future assessments more efficient and accurate, which is a major challenge for asbestos research today <xref ref-type="bibr" rid="scirp.146520-8">
      [8]
     </xref>. Policy research adaptation into future technological improvements should also be adopted to implement changes in regulations that will allow these benefits to be reaped. Moreover, a global lens approach that integrates information on modern-day socio-economic conditions, as mentioned in analyses of retrospective studies, to make sense of the disproportionate rates of decreasing mesothelioma cases in developed countries and increasing in some developing countries as compared to the nearness of being eliminated in 2006 of cases from exposure to asbestos in industrializing countries <xref ref-type="bibr" rid="scirp.146520-2">
      [2]
     </xref>, should also be prioritized in future research for global collaborations and partnerships that will allow the development of solutions to issues arising from the different trends and patterns, and will allow the establishment of a practical approach towards mesothelioma management. It is necessary to promote interdisciplinary research approaches in the future to meet these interdisciplinary demands resulting from the changing trends in asbestos exposure and the significant way that it occurs and continues to occur in societies today, for sustained improvements for public health and heightened global efforts for regulatory implementations that would allow these issues to be faced head-on.</p>
   </sec>
  </sec><sec id="s8">
   <title>
    <xref ref-type="bibr" rid="scirp.146520-"></xref>8. Limitations and Data Gaps</title>
   <p>Despite significant advances, several limitations remain. Many historical records of asbestos exposure are incomplete or missing, making it challenging to reconstruct precise exposure scenarios. The long latency period between exposure and disease onset complicates causal inference and risk estimation. Non-occupational exposures, such as those experienced by family members or through environmental contamination, are often underreported or poorly documented. These gaps highlight the ongoing need for improved data collection, more comprehensive surveillance, and analytic methods that can accommodate uncertainty.</p>
  </sec><sec id="s9">
   <title>9. Conclusions</title>
   <p>The manuscript uses a broad perspective to present information regarding the exposure to asbestos and the epidemiologic studies in the context of its association with a specific type of cancer, mesothelioma. Different approaches taken by scientists in applying different study methodologies, such as retrospective cohort studies and case-control studies, are used to understand the behavior of disease risks and epidemiological patterns. Reconstructing exposure history using company records, job history, and advanced exposure-metric modalities has been discussed in detail. It has elaborated on the challenges in reconstructing the exposure. Missing data and long latency, as well as emerging technologies like artificial intelligence and digital archives, have been highlighted to aid exposure reconstruction and early tumor detection. By merging history, scientific approaches, disease prevention methodologies, and policies, the manuscript has presented how a collaborative effort backed by technology has shaped the policies to protect public health from past exposure, improve current regulatory measures, and develop better regulatory guidelines.</p>
   <p>Furthermore, the association between asbestos exposure and mesothelioma is a multifaceted phenomenon that is enhanced by the use of rigorous research approaches and dose-response analysis. A thorough evaluation of past and present evidence has highlighted the need for effective prevention among vulnerable populations and their environments. Technological breakthroughs, such as machine learning, AI-based risk assessments, and precision imaging, have had a profound impact on our ability to identify hazards promptly and inform decisions. Collaboration between researchers, healthcare professionals, data scientists, regulators, and policymakers will allow for a translation between experimental evidence related to strong associations and real-world measures. Promoting innovative discovery and keeping up with the latest trends through continuous learning will facilitate progress in asbestos risk management efforts in occupational and public settings.</p>
  </sec>
 </body><back>
  <ref-list>
   <title>References</title>
   <ref id="scirp.146520-ref1">
    <label>1</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Burdett, G. (2024) Asbestos Exposure Measurements: Principles of Current and Historical Data Interpretation. In: Korchevskiy, A., Rasmuson, J. and Rasmuson, E., Ed., Health Risk Assessment for Asbestos and Other Fibrous Minerals, Wiley Online Library, 127-152.
    </mixed-citation>
   </ref>
   <ref id="scirp.146520-ref2">
    <label>2</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Zhao, Z., Li, J., Tan, F., Xue, Q., Gao, S. and He, J. (2025) Assessing the Global Burden of Mesothelioma: Trends, Socioeconomic Influences, and Asbestos Exposure—A Retrospective Cohort Study. International Journal of Surgery, 111, 93-103. &gt;https://doi.org/10.1097/js9.0000000000001900
    </mixed-citation>
   </ref>
   <ref id="scirp.146520-ref3">
    <label>3</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Carbone, M., Dodson, R., Pass, H. and Yang, H. (2024) Asbestos: Risk Assessment, Epidemiology, and Health Effects. CRC Press. 
    </mixed-citation>
   </ref>
   <ref id="scirp.146520-ref4">
    <label>4</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Consonni, D., Calvi, C., De Matteis, S., Mirabelli, D., Landi, M.T., Caporaso, N.E., et al. (2019) Peritoneal Mesothelioma and Asbestos Exposure: A Population-Based Case-Control Study in Lombardy, Italy. Occupational and Environmental Medicine, 76, 545-553. &gt;https://doi.org/10.1136/oemed-2019-105826
    </mixed-citation>
   </ref>
   <ref id="scirp.146520-ref5">
    <label>5</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Korchevskiy, A.A. and Korchevskiy, A. (2022) Non-Linearity in Cancer Dose-Response: The Role of Exposure Duration. Computational Toxicology, 22, Article 100217. &gt;https://doi.org/10.1016/j.comtox.2022.100217
    </mixed-citation>
   </ref>
   <ref id="scirp.146520-ref6">
    <label>6</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Korchevskiy, A.A. and Wylie, A.G. (2022) Asbestos Exposure, Lung Fiber Burden, and Mesothelioma Rates: Mechanistic Modelling for Risk Assessment. Computational Toxicology, 24, Article 100249. &gt;https://doi.org/10.1016/j.comtox.2022.100249&gt;https://www.sciencedirect.com/science/article/pii/S2468111322000378 
    </mixed-citation>
   </ref>
   <ref id="scirp.146520-ref7">
    <label>7</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Cox, L.A. (2019) Dose-Response Modeling of NLRP3 Inflammasome-Mediated Diseases: Asbestos, Lung Cancer, and Malignant Mesothelioma as Examples. Critical Reviews in Toxicology, 49, 614-635. &gt;https://doi.org/10.1080/10408444.2019.1692779
    </mixed-citation>
   </ref>
   <ref id="scirp.146520-ref8">
    <label>8</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Benlala, I., De Senneville, B.D., Dournes, G., Menant, M., Gramond, C., Thaon, I., et al. (2022) Deep Learning for the Automatic Quantification of Pleural Plaques in Asbestos-Exposed Subjects. International Journal of Environmental Research and Public Health, 19, Article 1417. &gt;https://doi.org/10.3390/ijerph19031417
    </mixed-citation>
   </ref>
   <ref id="scirp.146520-ref9">
    <label>9</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Lin, R., Chien, L., Jimba, M., Furuya, S. and Takahashi, K. (2019) Implementation of National Policies for a Total Asbestos Ban: A Global Comparison. The Lancet Planetary Health, 3, e341-e348. &gt;https://doi.org/10.1016/s2542-5196(19)30109-3&gt;https://www.thelancet.com/journals/lanplh/article/PIIS2542-5196(19)30109-3/fulltext
    </mixed-citation>
   </ref>
  </ref-list>
 </back>
</article>